bd 1047 has been researched along with ketamine in 2 studies
| Studies (bd 1047) | Trials (bd 1047) | Recent Studies (post-2010) (bd 1047) | Studies (ketamine) | Trials (ketamine) | Recent Studies (post-2010) (ketamine) |
|---|---|---|---|---|---|
| 118 | 0 | 54 | 15,029 | 2,321 | 6,678 |
| Protein | Taxonomy | bd 1047 (IC50) | ketamine (IC50) |
|---|---|---|---|
| Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 4.216 | |
| Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 4.216 | |
| Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 5.02 | |
| Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 5.02 | |
| Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 3.7762 | |
| Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 3.5563 | |
| Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 4.1059 | |
| Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 5.02 | |
| Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 5.02 | |
| Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 5.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elliott, M; Matsumoto, RR; Robson, MJ; Seminerio, MJ | 1 |
| Healy, JR; Matsumoto, RR; Nguyen, L; Robson, MJ; Scandinaro, AL | 1 |
2 other study(ies) available for bd 1047 and ketamine
| Article | Year |
|---|---|
Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo.
Topics: Animals; Anisoles; Antidepressive Agents; Dose-Response Relationship, Drug; Drug Interactions; Ethylenediamines; Ketamine; Male; Mice; Motor Activity; Nerve Growth Factor; Neurites; PC12 Cells; Propylamines; Radioligand Assay; Rats; Receptors, sigma | 2012 |
Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dextromethorphan; Dose-Response Relationship, Drug; Ethylenediamines; Excitatory Amino Acid Antagonists; Ketamine; Kinetics; Male; Mice; Piperazines; Protein Binding; Quinidine; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Sigma-1 Receptor; Swimming | 2014 |